S
06938
Suzhou Ribo Life Science
64.700
+0.350+0.54%Closed16:08 04/02 HKT
OPEN/PREV CLOSE64.600/64.350
TODAY RANGE61.000-65.500
VOL154.00K
MARKET CAP11.03B
52 WEEK RANGE51.200-95.800
AVG VOL (3M)654.10K
% TURNOVER0.09%
TURNOVER9.79M
P/E (TTM)-35.845
% RANGE6.99%
EPS(TTM)-1.805
P/E(FORWARD)-25.699
P/B-106.100
BVPS-0.610
DIVIDEND--
P/S67.116
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP10.17B
SHARES OUTSTANDING170.55M
NEXT EARNINGS--
FREE FLOAT157.13M
LOT SIZE200
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·03/26 11:19
Shrinking Losses At Suzhou Ribo Life Science (SEHK:6938) Test Bearish Profitability Narratives
Reuters·03/20 11:33
Suzhou Ribo Life Science Attends RNA Leaders Europe Conference in Vienna
Reuters·03/02 00:08
Suzhou Ribo to start China Phase III trial of RBD7022 for hyperlipidemia
Dow Jones·02/19 04:32
Suzhou Ribo's Swedish Clinical Team Likely Sets It Apart From Peers -- Market Talk
Dow Jones·02/19 04:22
*Suzhou Ribo Life Science Started at Outperform by Macquarie Capital >6938.HK
Simply Wall St·02/15 16:29
Suzhou Ribo Life Science (SEHK:6938) Valuation Check After Recent Share Price Weakness
Reuters·02/12 03:41
BUZZ-China's Suzhou Ribo Life Science jumps on Madrigal licensing deal
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.